CRNA — Circio Holding ASA Share News
0.000.00%
Last trade - 00:00- NOK1.79bn
- NOK1.80bn
Brief: Targovax Granted European Patent For Oncos-102
Brief: Targovax Q2 Operating Loss Narrows To NOK 29.7 Mln
Brief: Targovax Enters Collaboration With Oblique
Brief: Targovax: Presentation Of Pre-Clinical Data From Next Generation ONCOS At AACR Virtual Annual Conference
Brief: Targovax Announces Collaborative Agreement With Merck & Co
Brief: Targovax's ONCOS-102 Mesothelioma 12-Month Data Demonstrate Broad Immune Activation Linked To Clinical Benefit
Brief: Targovax Enters Collaboration With Leidos
Brief: Targovax Q1 Operating Loss Narrows To NOK 29.3 Million
Brief: Targovax Releases Update For Mesothelioma Trial Combining ONCOS-102 And Chemotherapy
Brief: Targovax, Valo Therapeutics Enter Collaboration To Develop RAS
Brief: Targovax Announces Proposed New Chairman Of The Board
Brief: Targovax Updates On Impact Of Coronavirus On Its Operations
Brief: Targovax: Board Of Directors Resolves To Not Proceed With Subsequent Offering
Brief: Targovax Successfully Completed Private Placement
Brief: Targovax Contemplates Private Placement
Brief: Targovax And IOVaxis Enter Option Agreement For TG Mutant RAS Vaccine License And Clinical Development In China
Brief: Targovax Q3 Operating Loss Narrows To NOK 26.7 Million
Brief: Targovax Q2 Operating Loss Widens To NOK 44.6 Million
Brief: Targovax Announces Encouraging Results From Part 1 Of The Oncos-102 And Keytruda Combination Trial In Anti-Pd1 Refractory Melanoma